8C60.0 Drug-induced myasthenia gravis International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 Some drugs can have clear effects on Myasthenia Gravis, including Neuromuscular junction blockers, antibiotics, prednisone, chloroquine, D-penicillamine, interferons, and others. In rapid-onset drug-induced Myasthenia Gravis, myasthenic signs develop within days which rapidly disappear after drug withdrawal. Anti-Acetylcholinesterase antibodies are absent. This disorder may unmask a pre-existing neuromuscular transmission disorder or may exacerbate pre-existing Myasthenia Gravis, i.e. subclinical Myasthenia Gravis becomes manifest after drug treatment, or known MG becomes more severe. Certain drugs are linked with aggravation of Myasthenia Gravis, including pain management medications, tricyclic antidepressants and some antiepileptic medications, and should be used with caution.
postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Associated with - multiple selections are allowed [select] PB20 Unintentional exposure to or harmful effects of opioids or related analgesics PB21 Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants PB22 Unintentional exposure to or harmful effects of psychostimulants PB23 Unintentional exposure to or harmful effects of cannabinoids or hallucinogens PB24 Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs PB25 Unintentional exposure to or harmful effects of antidepressants PB26 Unintentional exposure to or harmful effects of antipsychotics PB27 Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs PB28 Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance PB29 Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances PH40 Exposure to or harmful effects of undetermined intent of opioids or related analgesics PH41 Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants PH42 Exposure to or harmful effects of undetermined intent of psychostimulants PH43 Exposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens PH44 Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs PH45 Exposure to or harmful effects of undetermined intent of antidepressants PH46 Exposure to or harmful effects of undetermined intent of antipsychotics PH47 Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs – PH47.0 Harmful effects of or exposure to mixed antiepileptics, not elsewhere classified, undetermined intent – PH47.Z Undetermined intent: Harmful effects of and exposure to noxious substances: Drugs, medicaments or biological substances: Unspecified antiepileptics or antiparkinsonism drugs PH48 Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances PH49 Exposure to or harmful effects of undetermined intent of multiple drugs, medicaments or biological substances PL00 Drugs, medicaments or biological substances associated with injury or harm in therapeutic use PL01 Complementary or traditional medicines associated with injury or harm in therapeutic use PL01.0 Complementary or traditional medicines associated with injury or harm in therapeutic use, Herbal Preparations or Formulas PL01.1 Complementary or traditional medicines associated with injury or harm in therapeutic use, Dietary Supplements, Vitamins or Minerals PL01.2 Complementary or traditional medicines associated with injury or harm in therapeutic use, Complementary or Traditional Medicines, not elsewhere classified PL01.Y Other specified complementary or traditional medicines associated with injury or harm in therapeutic use PL01.Z Complementary or traditional medicines associated with injury or harm in therapeutic use, unspecified PL0Z Substances associated with injury or harm in therapeutic use, unspecified PL13 Mode of injury or harm associated with exposure to a drug, medicament or biological substance PL13.0 Overdose of substance, as mode of injury or harm PL13.1 Underdosing, as mode of injury or harm PL13.2 Drug-related injury or harm in the context of correct administration or dosage, as mode of injury or harm PL13.3 Incorrect substance, as mode of injury or harm PL13.5 Incorrect administration of drug or medicament, as mode of injury PL13.6 Medication or substance that is known to be an allergen, as mode of injury or harm PL13.7 Medication or substance that is known to be contraindicated for the patient, as mode of injury or harm PL13.8 Expired or deteriorated medication or substance, as mode of injury or harm PL13.9 Drug or substance interactions, as mode of injury or harm PL13.A Inappropriate stoppage or discontinuation of drug, as mode of injury or harm PL13.Y Other specified mode of injury or harm associated with exposure to a drug, medicament or biological substance PL13.Z Mode of injury or harm associated with exposure to a drug, medicament or biological substance, unspecified PL13.50 Incorrect route of drug or medicament, as mode of injury PL13.51 Incorrect rate of drug or medicament, as mode of injury PL13.52 Incorrect timing of drug or medicament, as mode of injury PL13.53 Incorrect duration of drug or medicament, as mode of injury PL13.5Y Other specified incorrect administration of drug or medicament, as mode of injury PL13.5Z Incorrect administration of drug or medicament, as mode of injury, unspecified
synonyms Drug-induced myasthenia gravis medicament-induced myasthenia gravis
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com